Effects of repeated administration of methamphetamine on P3-like potentials in rats

International Journal of Psychophysiology

Volumn 32, Issue 3, 1999, Pages 183-192

  Takeuchi, Satoshi ^a   Jodo, Eiichi ^a   Suzuki, Yoshiaki ^a   Matsuki, Tomohiko ^a   Niwa, Shin Ichi ^a   Kayama, Yukihiko ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Behavioral sensitization; Event related potentials; Methamphetamine; P3 like potential; P300; Rats; Schizophrenia

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED CORTICAL RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROTRANSMISSION; NONHUMAN; PSYCHOSIS; RAT; SCHIZOPHRENIA;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EVENT-RELATED POTENTIALS, P300; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PSYCHOSES, SUBSTANCE-INDUCED; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; STEREOTYPIC MOVEMENT DISORDER; TIME FACTORS;

EID: 0033061076     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8760(99)00016-1     Document Type: Article

References (53)

1. 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components. Biol. Psychiatry. 17:1982;1389-1402.
2. Andreasen N.C., Rezai K., Alliger R.et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch. Gen. Psychiatry. 49:1992;943-958.
3. Begleiter H., Porjesz B., Chou C.L., Aunon J.I. P3 and stimulus incentive value. Psychophysiology. 20:1983;95-101.
4. Brunswick D.J., Benmansour S., Tejani-Butt S.M., Hauptmann M. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse. 235:1992;93-103.
5. Buchwald, J.S., 1989. Comparisons of sensory and cognitive brain potentials in the human and in an animal model. In: Baser, E., Bullock, T. (Eds.), Springer Series in Brain Dynamics 2. Springer-Verlag, Berlin-Heidelberg, pp. 242-257.
6. Buchwald, J.S., 1990. Animal models of cognitive event-related potentials. In: Rohrbaugh, J.W., Parasuraman, R., Johnson, R. (Eds.), Event-Related Potentials: Basic Issues and Applications. Oxford University Press, pp. 57-75.
7. Connell, P.H., 1958. Amphetamine Psychosis. Oxford University Press, New York.
8. DeLisi L.E., Buchsbaum M.S., Holcomb H.H.et al. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. Am. J. Psychiatry. 142:1985;78-81.
9. Diamond A. Evidence for the importance of dopamine for prefrontal cortex functions early in life. Philos. Trans. R. Soc. London Ser. B: Biol. Sci. 351:1996;1483-1493.
10. Donchin E. Surprise!.surprise? Psychophysiology. 18:1981;493-513.
11. Ellinwood E.H., Sudilovsky A., Nelson L.M. Evolving behavior in the clinical and experimental (model) psychosis. Am. J. Psychiatry. 130:1973;1088-1092.
12. Ellinwood Jr., E.H., 1974. Amphetamine model psychosis: The relationships to schizophrenia. In: Mitsuda, H., Fukuda, T. (Eds.), Biological Mechanisms of Schizophrenia and Schizophrenia-Like Psychosis. Igaku-Shoin, Tokyo, pp. 89-96.
13. Friedman D., Squires-Wheeler E. Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophr. Bull. 20:1994;63-74.
14. Halperin, R., Phaff, D.W., 1982. Brain-stimulated reward and control of autonomic function: are they related? In: Phaff, D.W. (Ed.), The physiological Mechanisms of Motivation. Springer-Verlag, Berlin, pp. 337-375.
15. Hamamura T., Fibiger H.C. Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. Eur. J. Pharmacol. 237:1993;65-71.
16. Hawks D., Mitcheson M., Ogborne A., Edwards G. Abuse of methylamphetamine. Br. Med. J. 6:1969;715-721.
17. Hoebel B.G. Inhibition and disinhibition of self-stimulation and feeding: hypothalamic control and postingestional factors. J. Comp. Physiol. Psychol. 66:1968;89-100.
18. Hoebel B.G. Feeding and self stimulation. Ann. N.Y. Acad. Sci. 157:1969;758-778.
19. Ingvar D.H., Franzen G. Abnormalities of cerebral blood distribution in patients with chronic schizophrenia. Acta. Psychiatr. Scand. 50:1974;425-462.
20. Iwanami A., Suga I., Kato N., Nakatani Y., Kaneko T. Event-related potentials in methamphetamine psychosis during an auditory discrimination task. Eur. Arch. Psychiatry Clin. Neurosci. 242:1993;203-208.
21. Iwanami A., Kanamori R., Suga I., Kaneko T., Kamijima K. Reduced attention-related negative potentials in methamphetamine psychosis. J. Nerv. Ment. Dis. 183:1995;693-697.
22. Iwao H., Yamamoto Y., Hori K., Yamauchi T., Nomura M. Effects of discrimination learning on the rat striatal dopaminergic activity: a microdialysis study. Neuroreport. 8:1997;1095-1098.
23. Jodo E., Takeuchi S., Kayama Y. P3b-like potential of rats recorded in an active discrimination task. Electroencephalogr. Clin. Neurophysiol. 96:1995;555-560.
24. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
25. Kanzaki A., Akiyama K., Otsuki S. Subchronic methamphetamine treatment enhances oubain-induced striatal dopamine efflux in vivo. Brain Res. 569:1992;181-188.
26. Knight, R.T., 1990. Neural mechanisms of event-related potentials: evidence from human lesion studies. In: Rohrbaugh, J.W., Parasuraman, R., Johnson, R. (Eds.), Event-Related Potentials: Basic Issues and Applications. Oxford University Press, pp. 3-18.
27. Kolta M.B., Sherve P., De Souza V., Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
28. Kramer J.C., Fischman V.S., Littlefield D.C. Amphetamine abuse: pattern and effects of high dose taken intravenously. J. Am. Med. Assoc. 20:1967;305-309.
29. Mittleman G., Castaneda E., Robinson T.E., Valenstein E.S. The propensity for non-regulatory ingestive behavior is related to differences in dopamine systems: behavioral and biochemical evidence. Behav. Neurosci. 100:1986;213-220.
30. Molnar M. On the origin of the P3 event-related potential component. Int. J. Psychophysiol. 17:1994;129-144.
31. Nishikawa T., Mataga N., Takashima M., Toru M. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88:1983;195-203.
32. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents the development of sensitization to methamphetamine. Life Sci. 56:1995;1223-1229.
33. Olds M.E., Olds J. Approach-avoidance analysis of rat diencephalon. J. Comp. Neurol. 120:1963;259-283.
34. Paller, K.A., 1994. The neural substrates of cognitive event-related potentials: A review of animal models of P3. In: Heinze, H.J., Münte, T.F., Mangun, G.G.R. (Eds.), Cognitive Electrophysiology. Birkhauser, Boston-Basel-Berlin, pp. 300-333.
35. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates, 2nd ed. Academic Press, Sydney.
36. Phillips A.G., Megenson G.J. Effects of taste on self stimulation and induced drinking. J. Comp. Physiol. Psychol. 66:1968;654-660.
37. Pritchard W.S. Cognitive event-related potential correlates of schizophrenia. Psychological Bull. 100:1986;43-66.
38. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
39. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
40. Robinson T.E., Becker J.B., Young E.A., Akil H., Castaneda E. The effects of footshock stress on regional brain dopamine metabolism and pituitary β-endorphin release in rats previously sensitized to amphetamine. Neuropharmacology. 26:1987;679-691.
41. Roth W.T., Cannon E.H. Some features of the auditory evoked response in schizophrenia. Arch. Gen. Psychiatry. 27:1972;466-471.
42. Sato M., Numachi Y., Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull. 18:1992;115-122.
43. Seiden L.S., Fishman W.M., Schuster C.R. Long-term methamphetamine-induced changes in tolerant rhesus monkeys. Drug Alcohol Depend. 1:1976;215-219.
44. Sharp T., Zetterström T., Ljungberg T., Ungelstedt U. A direct comparison of amphetamine-induced behaviors and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
45. Snyder S.H. Catecholamines in the brain as mediators of amphetamine psychosis. Arch. Gen. Psychiatry. 27:1972;169-179.
46. Squires N.K., Squires K.C., Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr. Clin. Neurophysiol. 38:1975;387-401.
47. Sutton S., Tueting P., Zubin J., John E.R. Evoked-potential correlates of stimulus uncertainty. Science. 150:1965;1187-1188.
48. Trowill J.A., Panksepp J., Gandelman R. An incentive model of rewarding brain stimulation. Physiol. Rev. 76:1969;264-281.
49. Tsuchiya K., Inoue T., Izumi T., Hashimoto S., Koyama T. Effects of footshock stress on regional brain monoamine metabolism and the acquisition of conditioned freezing in rats previously exposed to repeated methamphetamine. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 20:1996;1239-1250.
50. Ujike H., Kanzaki A., Okumura K., Akiyama K., Otsuki S. Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci. 50:1993;129-134.
51. Utena, H., 1966. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. In: Tokizane, T., Schade, J.P. (Eds.), Progress in Brain Research, 21B, Correlative Neurosciences: Clinical Studies. Elsevier Science, Amsterdam, pp. 192-207.
52. Yamada S., Kojima H., Yokoo H.et al. Enhancement of dopamine release from striatal slice of rats that were subchronically treated with methamphetamine. Biol. Psychiatry. 24:1988;399-408.
53. Yano H., Higashi H., Nishi S. Actions of dopamine on prefrontal neurons from methamphetamine-pretreated rats. Kurume Med. J. 38:1991;337-339.